Preregistration of study design and non-inferiority margin

According to the registry at ClinicalTrials.gov (NCT00622284), the objective of Gallwitz and colleagues' trial was to investigate the efficacy, safety, and tolerability of linagliptin compared with glimepiride.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 2013-01, Vol.381 (9861), p.115-115
Hauptverfasser:	van Hateren, Kornelis JJ, Kleefstra, Nanne, Bilo, Henk J
Format:	Artikel
Sprache:	eng
Schlagworte:	Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Drug therapy Female Humans Hypoglycemic Agents - therapeutic use Internal Medicine Male Medical research Metformin - therapeutic use Purines - therapeutic use Quinazolines - therapeutic use Sulfonylurea Compounds - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	According to the registry at ClinicalTrials.gov (NCT00622284), the objective of Gallwitz and colleagues' trial was to investigate the efficacy, safety, and tolerability of linagliptin compared with glimepiride.
ISSN:	0140-6736 1474-547X
DOI:	10.1016/S0140-6736(13)60047-1